175 related articles for article (PubMed ID: 1974174)
21. Immune thrombocytopenia: antiplatelet autoantibodies inhibit proplatelet formation by megakaryocytes and impair platelet production in vitro.
Iraqi M; Perdomo J; Yan F; Choi PY; Chong BH
Haematologica; 2015 May; 100(5):623-32. PubMed ID: 25682608
[TBL] [Abstract][Full Text] [Related]
22. [Autoantibodies to the thrombocytes and erythrocytes in HIV-infected patients].
Kravchenko AV; Poliakova AM; Khasbekova SG; Donskov SI; Astrina OS; Maleev VV
Zh Mikrobiol Epidemiol Immunobiol; 1999; (1):78-80. PubMed ID: 10096215
[TBL] [Abstract][Full Text] [Related]
23. Relationship of antibodies against CD4+ T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion.
Müller C; Kukel S; Bauer R
Immunology; 1993 Jun; 79(2):248-54. PubMed ID: 8102120
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 and platelet protagonists in T lymphocyte and virological response.
Miguez MJ; Rodríguez A; Hadrigan S; Asthana D; Burbano X; Fletcher MA
Platelets; 2005 Aug; 16(5):281-6. PubMed ID: 16011978
[TBL] [Abstract][Full Text] [Related]
25. [Neutropenia in HIV infection].
Moreno García M
An Med Interna; 1997 Apr; 14(4):199-208. PubMed ID: 9181819
[TBL] [Abstract][Full Text] [Related]
26. Platelet-associated antibodies, cellular immunity and FCGR3a genotype influence the response to rituximab in immune thrombocytopenia.
Cooper N; Stasi R; Cunningham-Rundles S; Cesarman E; McFarland JG; Bussel JB
Br J Haematol; 2012 Aug; 158(4):539-47. PubMed ID: 22775462
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies to leukocyte alphaMbeta2 integrin glycoproteins in HIV infection.
Rubinstein DB; Farrington GK; O'Donnell C; Hartman KR; Wright DG
Clin Immunol; 1999 Mar; 90(3):352-9. PubMed ID: 10075864
[TBL] [Abstract][Full Text] [Related]
28. Use of protein A immunoadsorption as a treatment for thrombocytopenia in HIV-infected homosexual men: a retrospective evaluation of 37 cases.
Snyder HW; Bertram JH; Henry DH; Kiprov DD; Benny WB; Mittelman A; Messerschmidt GL; Cochran SK; Perkins W; Balint JP
AIDS; 1991 Oct; 5(10):1257-60. PubMed ID: 1786153
[TBL] [Abstract][Full Text] [Related]
29. Periodic production of antiplatelet autoantibody directed against GPIIIa in cyclic thrombocytopenia.
Yanabu M; Nomura S; Fukuroi T; Kawakatsu T; Kido H; Yamaguchi K; Suzuki M; Kokawa T; Yasunaga K
Acta Haematol; 1993; 89(3):155-9. PubMed ID: 8362605
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of platelet-associated immunoglobulins in narcotic addicts with human immunodeficiency virus infection.
Borradori L; Castelli D; Flueckiger E; Nydegger UE
Clin Immunol Immunopathol; 1990 Feb; 54(2):256-65. PubMed ID: 2295156
[TBL] [Abstract][Full Text] [Related]
31. Immunologic thrombocytopenic purpura in human immunodeficiency virus--seropositive patients with hemophilia. Comparison with patients with classic autoimmune thrombocytopenic purpura, homosexuals with thrombocytopenia, and narcotic addicts with thrombocytopenia.
Karpatkin S; Nardi MA
J Lab Clin Med; 1988 Apr; 111(4):441-8. PubMed ID: 3258345
[TBL] [Abstract][Full Text] [Related]
32. Effects of 3-azidothymidine on platelet counts, indium-111-labelled platelet kinetics, and antiplatelet antibodies.
Panzer S; Stain C; Benda H; Mannhalter C
Vox Sang; 1989; 57(2):120-6. PubMed ID: 2675461
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune neutropenia with cyclic oscillation of neutrophil count after steroid administration.
Hirase N; Abe Y; Muta K; Ishikura H; Umemura T; Nawata H; Nishimura J
Int J Hematol; 2001 Apr; 73(3):346-50. PubMed ID: 11345201
[TBL] [Abstract][Full Text] [Related]
34. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia.
Nardi MA; Liu LX; Karpatkin S
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7589-94. PubMed ID: 9207136
[TBL] [Abstract][Full Text] [Related]
35. Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients.
Amara A; Chaugier C; Ragnaud JM; Geffard M
Clin Exp Immunol; 1994 Jun; 96(3):379-83. PubMed ID: 7911749
[TBL] [Abstract][Full Text] [Related]
36. The evaluation of platelet indices and markers of inflammation, coagulation and disease progression in treatment-naïve, asymptomatic HIV-infected individuals.
Nkambule BB; Davison GM; Ipp H
Int J Lab Hematol; 2015 Aug; 37(4):450-8. PubMed ID: 25401263
[TBL] [Abstract][Full Text] [Related]
37. Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease.
de Noronha R; Taylor BA; Wild G; Triger DR; Greaves M
Clin Lab Haematol; 1991; 13(2):127-35. PubMed ID: 1934923
[TBL] [Abstract][Full Text] [Related]
38. An overview of the mechanisms of HIV-related thrombocytopenia.
Passos AM; Treitinger A; Spada C
Acta Haematol; 2010; 124(1):13-8. PubMed ID: 20606410
[TBL] [Abstract][Full Text] [Related]
39. Essential roles for platelets during neutrophil-dependent or lymphocyte-mediated defense against bacterial pathogens.
Wang Z; Zhao Q; Zhang D; Sun C; Bao C; Yi M; Xing L; Luo D
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):667-72. PubMed ID: 26588444
[TBL] [Abstract][Full Text] [Related]
40. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study.
Furuncuoğlu Y; Tulgar S; Dogan AN; Cakar S; Tulgar YK; Cakiroglu B
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1300-6. PubMed ID: 27097950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
